News

Specialty Contact Lens Travel Grants by Art Optical

Specialty Contact Lens Travel Grants by Art Optical

Art Optical Contact Lens, Inc., a provider of custom contact lenses, in partnership with Contamac, a manufacturer of contact and intraocular lens materials, recently named the winners of their Specialty Contact Lens Travel Grants. According to the announcement, these individuals have demonstrated the use of Art Optical lens designs to solve patient needs in unique…

Menicon ends Rose K manufacturing partnership with Blanchard Contact Lenses

Menicon ends Rose K manufacturing partnership with Blanchard Contact Lenses

Menicon Co., Ltd, a global contact lens manufacturer, announced that it has concluded its Rose K manufacturing partnership with Blanchard Contact Lenses, a division of CooperVision, effective December 31, 2025. Blanchard had been an important and valued Rose K partner since 2003, the company said, contributing more than two decades of expertise to the fitting,…

LENZ Therapeutics reports preliminary Q4 2025 results

LENZ Therapeutics reports preliminary Q4 2025 results

LENZ Therapeutics, Inc., a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%, has announced certain preliminary unaudited financial results for the fourth quarter ended December 31, 2025 and recent corporate updates. Approved by the FDA in August 2025, VIZZ is a once-daily aceclidine-based eye drop for the treatment of age-related presbyopia….

CLI names 2025 Culture Award Honorees

CLI names 2025 Culture Award Honorees

The Contact Lens Institute (CLI) has announced the winners of its 2025 Contact Lens Institute Culture Awards, recognizing five U.S. and Canadian eyecare teams and individuals. These honorees were selected for their successful efforts in cultivating contact lens cultures that lead to improved patient experiences and better business outcomes, the group advised. According to the…

The Eye Consortium adds Bausch + Lomb as partner

The Eye Consortium adds Bausch + Lomb as partner

The Eye Consortium (TEC), an alliance group for independent practices, has formed a new Elite Vendor partnership with Bausch + Lomb to help advance TEC’s ongoing commitment to deliver programs and resources that help the alliance’s member doctors elevate both the patient experience and practice profitability. “In response to the overwhelming interest from our membership,…

Prevent Blindness names Matt MacDonald as Chair of Board of Directors

Prevent Blindness names Matt MacDonald as Chair of Board of Directors

Prevent Blindness, has announced that Matt MacDonald, president and global head of managed care, EyeMed Vision Care, was appointed chair of its board of directors on November 14, at the 2025 Prevent Blindness annual board meeting here. MacDonald succeeds Jim McGrann, CEO of Advancing Eyecare, who was named an emeritus member of the board. At…

Custom contact lens manufacturer Scotlens unveils new brand identity

Custom contact lens manufacturer Scotlens unveils new brand identity

Scotlens, a leading custom contact lens manufacturer, has unveiled its refreshed brand identity at the Hospital and Specialty Optometrists Conference (8–9 November 2025). The rebrand follows its acquisition by Contact Lens Precision Laboratories (CLPL) six months ago and aligns Scotlens with CLPL and sister company Ultravision, which rebranded in 2024. “This integration strengthens our mission…

ONE by ONE Recycling program collects used contact lens

ONE by ONE Recycling program collects used contact lens

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced its ONE by ONE Recycling program has collected a total of 691,180 pounds, or 114,037,136 units, of used contact lens, eyecare and lens care materials in the United States. The program, created in collaboration with international recycling leader TerraCycle, continues to…

LENZ Therapeutics shares 3rd quarter financial results

LENZ Therapeutics shares 3rd quarter financial results

LENZ Therapeutics, Inc. the pharmaceutical company focused on the commercialization of recently FDA-approved VIZZ (aceclidine ophthalmic solution) 1.44%, has announced financial results for the third quarter ending September 30, 2025, as well as recent corporate highlights. Highlighted among those was the FDA approval in late July of VIZZ, an aceclidine-based eye drop for the treatment…

BostonSight Appoints Dr. Karen Carrasquillo as Chief Innovation and Education Officer

BostonSight Appoints Dr. Karen Carrasquillo as Chief Innovation and Education Officer

BostonSight, a nonprofit eye health care organization that advances the treatment of irregular corneas and ocular surface disease through specialty lenses, announced today that Karen Carrasquillo, OD, Ph.D., FAAO, FSLS, FBCLA, has been appointed to the new role of chief innovation and education officer, effective immediately. She formerly served as senior vice president, clinical and…